MediBeacon Inc.
Saint Louis, US · Founded 2012 · Delaware corporation · 31 employees on LinkedIn · 3 known investors
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
Founders & leadership
MediBeacon Inc. was founded in 2012 by Richard Dorshow.
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$87.5M disclosed across 10 rounds · 2012–2023
▶$16.1MraisedJan 2025 · 38 investors · Other Health CareRule 506(b)
- Steven MillerDirector
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Cherine PlumakerDirector
- Terence SternExecutive Officer
- Steven HanleyExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $16.1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMar 2023 · 11 investors · Other Health CareRule 506(b)
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- Richard DorshowExecutive Officer, Director
- David PresentDirector
- Cherine PlumakerDirector
- Terence SternExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.1MraisedJul 2022 · 25 investors · Other Health CareRule 506(b)
- Richard DorshowExecutive Officer, Director
- Terence SternExecutive Officer
- Cherine PlumakerDirector
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- David PresentDirector
- Offering amount
- $8.1M
- Amount sold
- $8.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.3MraisedSep 2019 · 7 investors · Other Health CareRule 506(b)
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Terence SternExecutive Officer
- Steven MillerDirector
- Cherine PlumakerDirector
- Steven HanleyExecutive Officer, Director
- Offering amount
- $34.8M
- Amount sold
- $34.3M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedDec 2018 · 2 investors · Other Health CareRule 506(b)
- Cherine PlumakerDirector
- David PresentDirector
- Terence SternExecutive Officer
- Steven MillerDirector
- Steven HanleyExecutive Officer, Director
- Richard DorshowExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJul 2018 · 11 investors · Other Health CareRule 506(b)
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- David PresentDirector
- Terence SternExecutive Officer
- Richard DorshowExecutive Officer, Director
- Cherine PlumakerDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $100K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedJan 2018 · 22 investors · Other Health CareRule 506(b)
- Terence SternExecutive Officer
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- Cherine PlumakerDirector
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $4.6M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.2MraisedMar 2017 · 3 investors · Other Health CareRule 506(b)
- Cherine PlumakerDirector
- Richard DorshowExecutive Officer, Director
- David PresentDirector
- Steven MillerDirector
- Steve HanleyExecutive Officer, Director
- Terence SternExecutive Officer
- Offering amount
- $11.2M
- Amount sold
- $11.2M
- Sales commissions
- $510K
- Placement agents
- Bruce Roberts
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with MediBeacon Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $181.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does MediBeacon Inc. do?
- MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
- Who founded MediBeacon Inc.?
- MediBeacon Inc. was founded by Richard Dorshow in 2012.
- Who are MediBeacon Inc.'s investors?
- MediBeacon Inc.'s investors include BioGenerator Ventures, Missouri Technology Corporation, Newlin Investment Company LLC.
- How much funding has MediBeacon Inc. raised?
- MediBeacon Inc. has disclosed $87.5M raised across 10 rounds.
- Where is MediBeacon Inc. headquartered?
- MediBeacon Inc. is headquartered in Saint Louis, US.


